Clinical Trials Directory

Trials / Unknown

UnknownNCT02016859

Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Dr. Yishai Ofran · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed that this value may be another prognostic factor in critically ill patients such as those admitted to ICU, or those with neutropenic Fever. The purpose of the study is to check if the IPF may be used as a prognostic Factor in these patients

Detailed description

In this study we have 3 groups of patients * Patients admitted to ICU * Patients admitted with neutropenic fever * Patients admitted with hip fractures it is a prospective study, not interventional, we'll take blood samples of these patients including CBC count eith IPF and other inflammation markers such as CRP and we'll compare CRP to IPF in addition to clinical follow-up of the patient till discharge. At the end of this study we'll compare the efficacy of IPF as a prognostic Factor in these patients

Conditions

Interventions

TypeNameDescription
OTHERImmature Platelet Fraction

Timeline

Start date
2014-01-01
Primary completion
2014-05-01
Completion
2014-11-01
First posted
2013-12-20
Last updated
2013-12-20

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02016859. Inclusion in this directory is not an endorsement.